Key result
The adipose tissue microenvironment and obesity play a complex role in promoting ovarian cancer onset, progression, and peritoneal metastasis, presenting a potential therapeutic target.
Why the study?
The specific roles of adipocytes and the adipose tissue microenvironment in ovarian cancer progression and peritoneal metastasis have not been fully elucidated.
The adipose tissue microenvironment, particularly in the context of obesity, may play a critical role in ovarian cancer progression and peritoneal metastasis, presenting a potential therapeutic target.
Adipose tissue may drive omental metastasis in ovarian cancer; leaves open mechanistic targets pending clinical validation.
Ovarian cancer is one of the most common gynecological malignancies and has low survival rates. One of the main determinants of this unfavorable prognosis is the high rate of peritoneal metastasis at diagnosis, closely related to its morbidity and mortality. The mechanism underlying peritoneal carcinomatosis is not clearly defined, but a clear preference for omental spread has been described. Growing evidence suggests that adipose tissue plays a role in promoting cancer onset and progression. Moreover, obesity can lead to changes in the original functions of adipocytes, resulting in metabolic and inflammatory changes in the adipose tissue microenvironment, potentially increasing the risk of tumor growth. However, the specific roles of adipocytes in ovarian cancer have not yet been fully elucidated. Due to the undeniable link between obesity and cancer, the adipose tissue microenvironment could also present a promising therapeutic target that warrants further research. This review discusses the complex relationship between ovarian cancer and the adipose tissue microenvironment.
No takes yet. Share an insight, caveat, or question.
Mendes et al. (2023) conducted a review in Ovarian cancer. Adipose tissue microenvironment and obesity was evaluated. The adipose tissue microenvironment and obesity play a complex role in promoting ovarian cancer onset, progression, and peritoneal metastasis, presenting a potential therapeutic target.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: